Clinical trials
Completed Achondroplasia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 4 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2022 | 3 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BioMarin Pharmaceutical | 7 |
| QED Therapeutics, a BridgeBio company | 3 |
| Ascendis Pharma A/S | 2 |
| Novo Nordisk A/S | 2 |
| Ascendis Pharma Growth Disorders A/S | 1 |
| Changchun GeneScience Pharmaceutical Co., Ltd. | 1 |
| National Human Genome Research Institute (NHGRI) | 1 |
| Nemours Children's Clinic | 1 |
| Pfizer | 1 |
| Sunnaas Rehabilitation Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Achondroplasia | 21 |
| Dwarfism | 12 |
| Genetic Diseases, Inborn | 7 |
| Bone Diseases | 6 |
| Musculoskeletal Diseases | 5 |
| Osteochondrodysplasias | 5 |
| Bone Diseases, Developmental | 4 |
| Mucopolysaccharidosis IV | 3 |
Trials
Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.